CCS
NGVT icon

Crosspoint Capital Strategies’s Ingevity NGVT Stock Holding History

Crosspoint Capital Strategies’s Portfolio NGVT Stock Details NGVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-148
Closed -$9K – 155
2017
Q1 		$9K Hold
148
– – 0.01% 69
2016
Q4 		$8K Buy
+148
New +$7.1K 0.01% 77

Other funds holding NGVT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
LCOV
London Company of Virginia Richmond, Virginia $16.2B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIC
Chilton Investment Company Stamford, Connecticut $4.26B AUM 1.32% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CCM
Channing Capital Management Chicago, Illinois $3.91B AUM 34.32% 1-Year Est. Return

Crosspoint Capital Strategies's NGVT Position: Q2 2017 in Review

Crosspoint Capital Strategies sold out of Ingevity (NGVT) in Q2 2017, closing a stake of 148 shares — an estimated $9K sold.

Crosspoint Capital Strategies first reported a position in NGVT in Q4 2016 and held it in 2 quarters. The position peaked at $9K in Q1 2017. 253 funds tracked by Wall St. Rank hold NGVT as of Q2 2017.

  • Crosspoint Capital Strategies reported no remaining Ingevity position as of Q2 2017 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 148 Ingevity shares in Q2 2017, an estimated $9K.
  • Crosspoint Capital Strategies first reported a position in Ingevity in Q4 2016 and held it in 2 quarters.
  • Crosspoint Capital Strategies's Ingevity position peaked at $9K in Q1 2017.
  • 253 funds tracked by Wall St. Rank held Ingevity as of Q2 2017.

Based on Crosspoint Capital Strategies's 13F filing for Q2 2017, filed 1 Aug 2017.